A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | Pain and Therapy
κ-opioid receptor - Wikipedia
Kappa opioid receptor binding affinity and the effects on... | Download Scientific Diagram
Opioid Receptor | kappa, mu Opioid Receptor
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | Pain and Therapy
Opioid Receptor Binding Affinities of Dynorphin Analogues. | Download Table
Predicting opioid receptor binding affinity of pharmacologically unclassified designer substances using molecular docking | PLOS ONE
Hot topics in opioid pharmacology: mixed and biased opioids - British Journal of Anaesthesia
Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor: Trends in Pharmacological Sciences
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Opioid receptor binding affinity (K i ) and antagonistic potency (K i )... | Download Table
Molecules | Free Full-Text | Ligand-Free Signaling of G-Protein-Coupled Receptors: Relevance to μ Opioid Receptors in Analgesia and Addiction
Nanobody-enabled monitoring of kappa opioid receptor states | Nature Communications
Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors - ScienceDirect
Noribogaine is a G-protein biased κ-opioid receptor agonist - ScienceDirect
Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists | Science Advances
Pharmaceuticals | Free Full-Text | Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Molecular mechanism of biased signaling at the kappa opioid receptor | Nature Communications